Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation

Virology

Volumn 409, Issue 1, 2011, Pages 102-112

  Danesh, Ali ^a,b   Cameron, Cheryl M ^a   León, Alberto J ^d   Ran, Longsi ^a   Xu, Luoling ^a   Fang, Yuan ^a,b   Kelvin, Alyson A ^c,g   Rowe, Thomas ^a,h   Chen, Honglin ^d   Guan, Yi ^d   Jonsson, Colleen B ^e   Cameron, Mark J ^a   Kelvin, David J ^a,d,f  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c IDR   (Canada)

^d SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^e Center for Predictive Medicine   (United States)

^f UNIVERSITY OF SASSARI   (Italy)

^g Porto Conte Ricerche Srl   (Italy)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Ferret; Gene expression; Interferon; SARS

Indexed keywords

ALPHA2B INTERFERON; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; GAMMA INTERFERON RECEPTOR 1; STAT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; FERRET; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; IMMUNOSTIMULATION; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA ANALYSIS; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; UPREGULATION; VIRUS CELL INTERACTION;

ANIMALS; DISEASE MODELS, ANIMAL; FERRETS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON ALFA-2B; MALE; MOLECULAR SEQUENCE DATA; PROTEINS; SARS VIRUS; SEQUENCE ANALYSIS, DNA; SEVERE ACUTE RESPIRATORY SYNDROME; STAT1 TRANSCRIPTION FACTOR; UP-REGULATION;

MUSTELA; SARS CORONAVIRUS;

EID: 78649445187     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.10.002     Document Type: Article

References (32)

1. Barclay J.L., Anderson S.T., Waters M.J., Curlewis J.D. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells. Mol. Endocrinol. 2007, 21:2503-2515.
2. Bonnevie-Nielsen V., Field L.L., Lu S., Zheng D.J., Li M., Martensen P.M., Nielsen T.B., Beck-Nielsen H., Lau Y.L., Pociot F. Variation in antiviral 2', 5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am. J. Hum. Genet. 2005, 76:623-633.
3. Bosinger S.E., Li Q., Gordon S.N., Klatt N.R., Duan L., Xu L., Francella N., Sidahmed A., Smith A.J., Cramer E.M., Zeng M., Masopust D., Carlis J.V., Ran L., Vanderford T.H., Paiardini M., Isett R.B., Baldwin D.A., Else J.G., Staprans S.I., Silvestri G., Haase A.T., Kelvin D.J. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J. Clin. Invest. 2009, 119(12):3556-3572.
4. Cameron M.J., Ran L., Xu L., Danesh A., Bermejo-Martin J.F., Cameron C.M., Muller M.P., Gold W.L., Richardson S.E., Poutanen S.M., Willey B.M., Devries M.E., Fang Y., Seneviratne C., Bosinger S.E., Persad D., Wilkinson P., Greller L.D., Somogyi R., Humar A., Keshavjee S., Louie M., Loeb M.B., Brunton J., McGeer A.J., Kelvin D.J. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 2007, 81:8692-8706.
5. Cameron C.M., Cameron M.J., Bermejo-Martin J.F., Ran L., Xu L., Turner P.V., Ran R., Danesh A., Fang Y., Chan P.K., Mytle N., Sullivan T.J., Collins T.L., Johnson M.G., Medina J.C., Rowe T., Kelvin D.J. Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J. Virol. 2008, 82:11308-11317.
6. Chelbi-Alix M.K., Wietzerbin J. Interferon, a growing cytokine family: 50years of interferon research. Biochimie 2007, 89:713-718.
7. Chevaliez S., Pawlotsky J.M. Interferon-based therapy of hepatitis C. Adv. Drug Deliv. Rev. 2007, 59:1222-1241.
8. Chu Y.K., Ali G.D., Jia F., Li Q., Kelvin D., Couch R.C., Harrod K.S., Hutt J.A., Cameron C., Weiss S.R., Jonsson C.B. The SARS-CoV ferret model in an infection-challenge study. Virology 2008, 374:151-163.
9. Corssmit E.P., Heijligenberg R., Hack C.E., Endert E., Sauerwein H.P., Romijn J.A. Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin. Exp. Immunol. 1997, 107(2):359-363.
10. Danesh A., Seneviratne C., Cameron C.M., Banner D., Devries M.E., Kelvin A.A., Xu L., Ran L., Bosinger S.E., Rowe T., Czub M., Jonsson C.B., Cameron M.J., Kelvin D.J. Cloning, expression and characterization of ferret CXCL10. Mol. Immunol. 2008, 45:1288-1297.
11. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Bridges C.B., Uyeki T.M. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009, 360:2605-2615.
12. Dushoff J., Plotkin J.B., Viboud C., Earn D.J., Simonsen L. Mortality due to influenza in the United States-an annualized regression approach using multiple-cause mortality data. Am. J. Epidemiol. 2006, 163:181-187.
13. Fang Y., Rowe T., Leon A.J., Banner D., Danesh A., Xu L., Ran L., Bosinger S.E., Guan Y., Chen H., Cameron C.C., Cameron M.J., Kelvin D.J. Molecular characterization of in vivo adjuvant activity in influenza-vaccinated ferrets. J. Virol. 2010, 84:8369-8388.
14. Gharavi N.M., Alva J.A., Mouillesseaux K.P., Lai C., Yeh M., Yeung W., Johnson J., Szeto W.L., Hong L., Fishbein M., Wei L., Pfeffer L.M., Berliner J.A. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J. Biol. Chem. 2007, 282:31460-31468.
15. Haagmans B.L., Kuiken T., Martina B.E., Fouchier R.A., Rimmelzwaan G.F., Van Amerongen G., van Riel D., de Jong T., Itamura S., Chan K.H., Tashiro M., Osterhaus A.D. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 2004, 10:290-293.
16. Haller O., Staeheli P., Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 2007, 89:812-818.
17. Hull R.B., Loosli C.G. Adrenocorticotrophic hormone (ACTH) in the treatment of experimental air-borne influenza virus type A infection in the ferret. J. Lab. Clin. Med. 1951, 37:603-614.
18. Kolling U.K., Hansen F., Braun J., Rink L., Katus H.A., Dalhoff K. Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia. Thorax 2001, 56:121-125.
19. Li H., Gade P., Xiao W., Kalvakolanu D.V. The interferon signaling network and transcription factor C/EBP-beta. Cell. Mol. Immunol. 2007, 4:407-418.
20. Loutfy M.R., Blatt L.M., Siminovitch K.A., Ward S., Wolff B., Lho H., Pham D.H., Deif H., LaMere E.A., Chang M., Kain K.C., Farcas G.A., Ferguson P., Latchford M., Levy G., Dennis J.W., Lai E.K., Fish E.N. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 2003, 290:3222-3228.
21. Marijanovic Z., Ragimbeau J., van der H.J., Uze G., Pellegrini S. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem. J. 2007, 407:141-151.
22. Martina B.E., Haagmans B.L., Kuiken T., Fouchier R.A., Rimmelzwaan G.F., Van Amerongen G., Peiris J.S., Lim W., Osterhaus A.D. Virology: SARS virus infection of cats and ferrets. Nature 2003, 425:915.
23. Ochi A., Danesh A., Seneviratne C., Banner D., Devries M.E., Rowe T., Xu L., Ran L., Czub M., Bosinger S.E., Cameron M.J., Cameron C.M., Kelvin D.J. Cloning, expression and immunoassay detection of ferret IFN-gamma. Dev. Comp. Immunol. 2008, 32:890-897.
24. Okumura A., Lu G., Pitha-Rowe I., Pitha P.M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1440-1445.
25. Rowe T., Leon A.J., Crevar C.J., Carter D.M., Xu L., Ran L., Fang Y., Cameron C.M., Cameron M.J., Banner D., Ng D.C., Ran R., Weirback H.K., Wiley C.A., Kelvin D.J., Ross T.M. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 2010, 401:257-265.
26. Shapira S.D., Gat-Viks I., Shum B.O., Dricot A., de Grace M.M., Wu L., Gupta P.B., Hao T., Silver S.J., Root D.E., Hill D.E., Regev A., Hacohen N. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139(7):1255-1267.
27. Staal F.J., Luis T.C., Tiemessen M.M. WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 2008, 8(8):581-593.
28. Storey J.D., Xiao W., Leek J.T., Tompkins R.G., Davis R.W. Significance analysis of time course microarray experiments. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(36):12837-12842.
29. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell. Microbiol. 2006, 8:907-922.
30. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
31. Uddin S., Platanias L.C. Mechanisms of type-I interferon signal transduction. J. Biochem. Mol. Biol. 2004, 37:635-641.
32. Weiss R.A., McMichael A.J. Social and environmental risk factors in the emergence of infectious diseases. Nat. Med. 2004, 10:S70-S76.